<DOC>
	<DOCNO>NCT02803268</DOCNO>
	<brief_summary>A Study Investigate Safety , Tolerability Pharmacokinetics Multiple Doses MT-8554 Female Subjects Experiencing Vasomotor Symptoms</brief_summary>
	<brief_title>A Study Investigate Safety , Tolerability Pharmacokinetics Multiple Doses MT-8554 Female Subjects Experiencing Vasomotor Symptoms</brief_title>
	<detailed_description />
	<criteria>Subjects must meet one follow criterion : Woman age ≥18 year histologically proven nonmetastatic breast cancer ( Stages I , II III ) without evidence disease / Woman age ≥40 year postmenopausal / Woman age ≥40 year perimenopausal Subjects ≥7 Vasomotor Symptoms per day average A body weight ≥45 kg Participation three clinical study involve administration unlicensed Investigational Medicinal Product previous year , study within 12 week Clinically significant endocrine , thyroid , hepatic , respiratory , gastrointestinal , renal , cardiovascular disease , history significant psychiatric/psychotic illness disorder Clinically relevant abnormal medical history , physical finding laboratory value</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>